Enzo Biochem Inc. - ENZ Net Assets per Single Share

Graphic logo of Enzo Biochem (ENZ)

Enzo Biochem, Inc. (ENZ) maintains business stability through reagent sales and strict cost control following the divestiture of its laboratories. An extensive DNA labeling patent portfolio serves as a defense against fierce competition. However, geopolitical fragmentation hinders test exports and scientific exchange. Changes in BVPS demonstrate capital resilience, with 0.89 representing the current level of this metric.

ENZ: Enzo Net Asset Value per Share 07/04/2022 - 04/26/2025

Enzo Biochem Inc. - analytical breakdowns and key metrics (ENZ)

- price and consensus price forecast:
Stock Quotes Enzo|ENZ - Forecast Levels Chart
- market capitalization data:
Market Value Enzo Biochem, Inc.|ENZ - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Enzo Biochem|ENZ - Total Stockholders' Equity|Market Capitalization to Book Value Ratio enzo.com|ENZ - Total Business Assets
- debt and liquidity data:
Total Debt to Capital Enzo Biochem, Inc.|ENZ - Long-Term Debt to Capital|Short-Term Debt to Equity Enzo|ENZ - Company Aggregate Debt|Debts to Book Capitalization Enzo Biochem, Inc.
Analysis of all company metrics:enzo.com (ENZ)
Manufactured products of Enzo

It is critical for investors to determine whether the current market price justifies the actual asset value of Enzo Biochem, Inc. (ENZ) amid operational risks. When analyzing the projected book value per share, one must evaluate net equity minus liabilities, which in this instance confirms the effectiveness of business diversification between diagnostic services and the commercialization of biotechnological patents.

Competitor analysis for Enzo Biochem, Inc.

Accounting Value per Share Agilent Tech|DGX: Share Book Value|ILMN (Illumina, Inc.) - Net Assets per Single Share|exactsciences.com (EXAS) - Accounting Value per Share|Book Value per Share RVTY (Revvity)|Net Asset Value per Share Bio-Rad Laboratories, Inc.|Book Value per Share Anbio Tech NNNN|Equity per Share Nordion (SHC)|Book Value per Share QDEL (QuidelOrtho)|opko.com - Book Value per Share|CareDx, Inc (CDNA) - Net Assets per Single Share|MRVI - Equity per Share|FLGT: Book Value per Share|LAB (Standard BioTools Corp) - Book Value per Share|Net Assets per Single Share Cytek Biosciences, Inc.|Net Assets per Single Share orasure.com (OSUR)|Exagen Inc. - Accounting Value per Share|Net Asset Value per Share MDXH (MDxHealth S.A.)|Net Assets per Single Share LUCD|Net Assets per Share Prenetics Global Limited PRE|Book Value per Share IMDX (Insight Molecular)|TRIB: Net Assets per Share|ProPhase Labs - Net Assets per Single Share|Ainos Inc (AIMD) - Net Assets per Share|Book Value per Share CODX (Co-Diagnostics Corp)|Net Asset Value per Share HSCS|Net Assets per Single Share Biomerica, Inc. BMRA|Equity per Share cardiodiagnosticsinc.com CDIO|Virax Biolabs (VRAX) - Accounting Value per Share|Bluejay Diagnostics Inc - Share Book Value|AWH (Vermillion) - Net Assets per Single Share|Accelerate Diagnostics Inc (AXDX) - Net Asset Value per Share|Accounting Value per Share centogene.com CNTG|Fresh2 Group (FRES) - Accounting Value of a Share|Book Value per Share Genetic Technologies Ltd|Net Assets per Single Share 23andMe Holding Co|PMD (Psychemedics Corp) - Book Value per Share